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Abstract
Background: Glomerulonephritis in dogs has been associated with B. burgdorferi infections. In
Bernese Mountain Dogs with glomerulonephritis antibodies against B. burgdorferi have been found
in most dogs, raising the question if the breed is predisposed to infections with B. burgdorferi. The
aim of this study was to determine the prevalence of antibodies against B. burgdorferi sensu lato in a
well defined population of Bernese Mountain Dogs and to compare this prevalence with data from
dogs of other breeds.
Results: 160 Bernese Mountain Dogs and 62 control dogs (large breed dogs with long hair) were
included. All dogs were considered healthy according to a questionnaire filled out by the owner,
complete blood count, chemistry panel, urinalysis and urine culture. Bernese Mountain Dogs and
control dogs were kept in similar environments. Seroprevalence of B. burgdorferi was assessed by
ELISA and Western blot and was 58% in Bernese Mountain Dogs compared to 15% in control dogs.
This difference was significant. Neither antibodies against leptospires nor vaccination or hair coat
color influenced the results.
Conclusion: The cause of the considerably higher prevalence of antibodies against B. burgdorferi
in Bernese Mountain Dogs and it's consequences are not known. A breed predisposition can be
suspected.
Background
Glomerulonephritis in dogs has been associated with B.
burgdorferi  infections [1-5] and in some studies spiro-
chetes were detected in the kidneys [2,3] and the urine [2].
However some of the authors questioned the relationship
of a renal lesion with B. burgdorferi [1,3]; still others
assumed B. burgdorferi to be the causative agent for renal
lesions [2]. In Bernese Mountain Dogs, a familial glomer-
ulonephritis was reported [4,5]. However, antibodies
against B. burgdorferi were found in most dogs, raising the
question of whether the occurrence of glomerular disease
in Bernese Mountain Dogs is related to an infection with
B. burgdorferi or if the breed is predisposed to infections
with B. burgdorferi.
The aim of this study was to determine the prevalence of
antibodies against B. burgdorferi sensu lato in a well defined
population of Bernese Mountain Dogs and to compare
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this prevalence with data from dogs of other breeds from
a similar environment.
Results
Dogs
One hundred and sixty Bernese Mountain Dogs and 62
control dogs were included in the study. Age, gender, hair
coat color and breed are depicted in Table 1. Bernese
Mountain Dogs were significantly younger than the con-
trol dogs (p = 0.01). Gender distribution was the same in
both groups (p = 0.41). Fifty-six of the 62 control dogs
belonged to 8 different long haired large breeds. The
remaining 6 dogs were mixed-breed dogs with Collie, Ger-
man Shepherd and Flat-Coated Retriever as dominant
breeds.
The geographical distribution of the places where the dogs
lived is depicted in (Figure 1).
The evaluation of the replies given to the questionnaires
are depicted in Table 2. Analysis of the answers only
revealed significant differences between the groups for the
frequency of attached ticks. Significantly more Bernese
Mountain Dog owners (44%) answered yes to the ques-
tion whether the dogs often had attached ticks compared
to owners of control dogs (25%; p = 0.01). The signifi-
cance disappeared if only dark haired control dogs (n =
20) were compared with Bernese Mountain Dogs even
though the percentage remained the same (25% and 44%
respectively; p= 0.08).
The answers to the questions about the environment in
which the dogs lived are depicted in Table 3. Significant
differences were found between dogs which lived in a
rural or a urban environment and for the percentage of
time spent in the woods. A significantly larger number of
Bernese Mountain Dogs (95%) lived in rural areas com-
pared to control dogs (79%; p = 0.001). Looking at the
two groups separately, living in rural areas did not lead to
a higher prevalence in antibodies against B. burgdorferi
compared to an urban environment. The reported per-
centage of time spent in the woods during walks was sig-
nificantly higher in Bernese Mountain Dogs with
antibodies against B. burgdorferi compared to those with-
out them (p = 0.049). In control dogs no significant dif-
ference was found (p = 0.90).
Antibodies against B. burgdorferi
In 160 Bernese Mountain Dogs and in 61 control dogs
antibodies against B. burgdorferi were determined with
both an ELISA and a Western blot. Of the Bernese Moun-
tain Dogs, 92 (58%) had a positive ELISA with a positive
Western blot, while in the control dogs this only hap-
pened in 9 (15%) dogs. This difference was significant (p
< 0.001). In positive dogs ODs ranged from 0.21 to 2.00
(median 0.75) in negative dogs from 0.04 to 1.28
(median 0.18) (Figure 2). The ODs of positive Bernese
Mountain Dogs were significantly higher than those of
positive control dogs (p < 0.001). Seropositive dogs had 1
to 7 bands in the Western blot (median 4) while seroneg-
ative dogs had 0 to 3 bands (median 0) (Figure 3). The
serology results are summarizes in Table 4. Control dogs
with a dark coat had significantly more antibodies against
B. burgdorferi (28%) when compared with control dogs
with a fair coat (7%; p = 0.03). Bernese Mountain Dogs
whose owners reported frequently attached ticks did not
have antibodies against B. burgdorferi significantly more
often (69%) compared to Bernese Mountain dogs whose
owners reported infrequently attached ticks (55%; p =
0.07). Control dogs whose owners reported frequently
attached ticks did not have antibodies against B. burgdor-
feri  significantly more often than control dogs whose
Table 1: Breed, age, gender and hair coat color of dogs included in the study
Breed number of dogs Age1 [years] Gender [number of dogs] hair coat color
Range Median f fs m mn
Bernese Mountain Dogs 160 1–11 4 94 21 35 10 dark
Landseer 28 1–12 5 16 2 8 2 fair
Newfoundland 12 3–8 6 9 1 2 0 dark
Flat-coated Retriever 8 1–7 1 4 0 3 1 dark
Golden Retriever 3 1–5 4 3 0 0 0 fair
Saint Bernard 2 2/5 3.5 1 1 0 0 fair
Belgian Sheppard 1 2 2 1 0 0 0 fair
Mastin de los Pirineos 1 11 11 0 0 1 0 fair
Tibetan Mastiff 1 5 5 0 0 1 0 fair
Mixed breed dogs 6 2–8 6.5 0 1 1 4 5 fair, 1 dark
Control dogs total 62 1–12 5 34 5 16 7 41 fair, 21 dark
f = female, fs = female spayed, m = male, mk = male neutered
1Significant difference between Bernese Mountain Dogs and control dogs (p = 0.01).BMC Veterinary Research 2007, 3:15 http://www.biomedcentral.com/1746-6148/3/15
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owners reported infrequently attached ticks (23% and
13% respectively; p = 0.30).
Comparison of antibodies against B. burgdorferi and 
against leptospires
Of 92 Bernese Mountain Dogs with antibodies against B.
burgdorferi, 53 (58%) had antibodies against leptospires as
well and of the 68 without antibodies against B. burgdor-
feri, 33 (49%) had antibodies against leptospires (p =
0.16). Of 9 control dogs with antibodies against B. burg-
dorferi there were 6 (67%) with antibodies against lepto-
spires. and of 53 negative control dogs 28 (53%) had
antibodies against leptospires (p = 0.35).
Antibodies against B. burgdorferi and vaccination against 
Lyme borreliosis
Four Bernese Mountain dogs and 6 control dogs had been
vaccinated against Lyme borreliosis. All 4 Bernese Moun-
tain dogs had a positive ELISA but only 3 had a positive
Western blot. Of the 6 control dogs, 3 had a positive ELISA
and a positive Western blot and 3 were negative on both
tests.
Discussion
The higher prevalence of antibodies against B. burgdorferi
in Bernese Mountain Dogs indicates a breed predisposi-
tion. Susceptibility in some breeds to a certain infection is
known from other diseases. For instance Rottweiler,
American Pit Bull Terrier, Doberman Pinscher, Pomera-
nian, and German Sheperd Dog are breeds at significantly
greater risk for parvovirus enteritis than mixed breed dogs
[6]. The reason is not known. However common ancestry
has been associated with this. Intense breeding might
have led to a decrease in defense against infections. This
might also be true for Bernese Mountain Dogs, a breed
that is known for intense breeding and that has a narrow
gene pool. This is supported by the fact that several dis-
eases are prevalent in Bernese Mountain Dogs such as
bleeding tendency, epilepsy, and malignant histiocytosis
[7-11]. However no infections have been described so far.
In Cavalier King Charles Spaniels a breed that was known
to be prone to Pneumocystis pneumonia infections, it was
found that there was a immunoglobulin deficiency in the
affected dogs indicating defect in immunity in these dogs
[12]. The findings in the present study are unique as infec-
tions with B. burgdorferi are not causing disease. Further-
more, no immunodeficiency is known in Bernese
Mountain Dogs. At the time, B. burgdorferi was associated
with glomerulonephritis in Bernese Mountain Dog, no
direct relation to the disease could be made. It is possible
that the Bernese Mountain Dogs with glomerulonephritis
in this study had antibodies against B. burgdorferi because
the over all prevalence of antibodies was so high in this
breed [5]. Labrador- and Golden Retrievers were found to
be overrepresented in a group of dogs with distinctive
renal lesions attributed to Lyme disease and also among
seropositive dogs in a survey performed in Texas [1,13],
indicating some breed predilection for B. burgdorferi infec-
tions. However Bernese Mountain Dogs were not men-
tioned in the studies.
It is well established that Borrelia organisms evade the
immune system in different ways and host factors become
more important the less pathogen the responsible organ-
isms are [14,15]. In human patients with Lyme disease-
associated erythema migrans, the carriage rate of leuko-
cyte class II alleles DRB1*0101 and DRB1*0101-
DQB1*0501 was higher in patients with the least patho-
gen B. burgdorferi genotype [15]. The immunologic event
causing this association was not known but as DRB1 alle-
les are located close to certain major histocompatibility
complex-encoded complement genes, it was speculated
that variants of these complement genes might be in link-
age disequilibrium with the DRB1 alleles [15,16]. The
innate immune response plays an important role in the
early response of Borrelia [17] but it also plays a role in
the development of certain glomerular diseases. Dogs
with a genetically determined deficiency of complement
C3 more often develop renal and infectious diseases [18].
The occurrence of a complement disturbance would
explain the co-occurrence of infection with B. burgdorferi
and glomerular disease. However no such disturbance is
known in Bernese Mountain Dogs so far.
In one study 5% to 34% of the I. ricinus ticks in Switzer-
land were infected with B. burgdorferi and infected ticks
were found in all areas where ticks were collected [19].
These figures remained stable in later studies [20-25].
Map of Switzerland with the geographical distribution of  tested dogs Figure 1
Map of Switzerland with the geographical distribu-
tion of tested dogs. Origin of Bernese Mountain Dogs (red 
dots) and control dogs (blue dots).BMC Veterinary Research 2007, 3:15 http://www.biomedcentral.com/1746-6148/3/15
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Even though owners of control dogs reported more often
that they lived in urban areas, the Bernese Mountain Dogs
and the control dogs in the present study were kept simi-
lar, lived in the same areas of Switzerland, were walked in
the same frequency and for the equal amount of time in
the woods. In addition all tick-infested areas in Switzer-
land harbor infected ticks. Based on this Bernese Moun-
tain Dogs did not appear to have a higher risk of tick
exposure compared to control dogs. Furthermore in a
Dutch study, prevalence of antibodies were not different
between dogs considered at high risk to a B. burgdorferi
infection (hunting dogs) and those considered at low risk
(pet dogs) [26]. One explanation for this was that the rate
of outdoor walking in house dogs was considered higher
and this also applies to Bernese Mountain Dogs or other
large breed dogs in Switzerland. Nevertheless Bernese
Mountain Dog owners in this study reported that their
dogs had attached ticks more often than owners of control
dogs and it is known that seropositivity among dogs is
positively associated with increased tick exposure [27].
However the question whether the dogs had attached ticks
more often was not specified and was therefore subject to
Table 2: Evaluation of replies to questions regarding health status of the dogs by questionnaire
Bernese Mountain Dogs Control dogs
B. burgdorferi serology total B. burgdorferi serology total
positive negative positive negative
hair color hair color
fair dark fair dark
Does your dog often have attached ticks?1 Yes 40 18 58 1 2 7 3 13
No 40 33 73 1 4 24 11 40
Do you perform tick prevention? Yes 52 38 90 2 6 23 5 36
No 26 14 40 0 0 7 7 14
Did your dog suffer from infectious diseases? No 62 47 109 2 3 25 12 42
Y e s 1 5 4 1 903521 0
General health Normal 80 52 132 2 6 30 14 52
Abnormal 0 0 0 0 0 0 0 0
Endurance Normal 76 50 126 2 6 28 14 50
D e c r e a s e d 4 2 60020 2
Weight loss No 75 52 127 2 6 30 14 52
Y e s 3 1 40000 0
Skin normal Yes 69 48 117 1 6 28 14 49
N o 9 4 1 31020 3
Appetite Normal 72 50 122 1 6 30 14 51
D e c r e a s e d 5 2 70000 0
I n c r e a s e d 1 0 11000 1
Thirst Normal 72 52 124 2 6 29 14 51
D e c r e a s e d 5 0 50010 1
I n c r e a s e d 1 0 10000 0
Vomiting No 77 52 129 2 6 29 14 51
Y e s 1 0 10010 1
Coughing No 77 52 129 2 6 30 14 52
Y e s 0 0 00000 0
Urine volume Normal 74 52 126 2 6 30 14 52
D e c r e a s e d 1 0 10000 0
I n c r e a s e d 1 0 10000 0
Defecation Normal 76 51 76 2 6 30 14 52
Diarrhea 2 1 2 0 0 0 0 0
Lameness No 46 36 46 1 6 24 14 45
Y e s 5 3 51060 7
Fever No 80 53 80 2 6 30 14 52
Y e s 0 0 00000 0
Edema No 51 39 51 2 6 30 14 52
Y e s 0 0 00000 0
1Significant difference between Bernese Mountain Dogs and control dogs (p = 0.01).BMC Veterinary Research 2007, 3:15 http://www.biomedcentral.com/1746-6148/3/15
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the individual judgment of the owner. Furthermore nei-
ther the Bernese Mountain Dogs nor the control dogs
which had a high frequency of attached ticks reported,
had a significantly higher prevalence of antibodies against
B. burgdorferi compared to those which did not frequently
have ticks.
A possible reason for the increased exposure of Bernese
Mountain Dogs was the dark hair coat. In dark hair it is
more difficult for the owner to detect ticks than in dogs
with fair hair color. This would allow more time for the
Borrelia species to move from the tick to the host and
infect the dogs [28-30]. In the control dogs it could be
shown that the ones with dark hair had significantly more
often antibodies than those with fair hair (28% versus
7%). However, if dark haired control dogs were compared
with Bernese Mountain Dogs, it could be seen that they
also had significantly less often antibodies against B. burg-
dorferi compared to Bernese Mountain Dogs even though
statistically significant differences in reported tick expo-
sure disappeared. This indicates that hair color is not the
explanation for the higher seroprevalence of antibodies
against B. burgdorferi in Bernese Mountain Dogs. Further-
more it was found that people with white clothing
attracted more ticks than people in dark clothing in the
same environment over the same time period, indicating
that fair hair might even attract more ticks than dark hair
[31].
Results of serologic tests are not consistent. The specificity
of whole cell ELISAs is limited because of cross reactivity
with other organisms [32]. Even though Western blot was
performed for the confirmation of the ELISA results anti-
bodies of leptospires were measured to rule out cross reac-
Table 3: Evaluation of replies to questions asked by telephone interview regarding the environment the dogs lived in
Bernese Mountain 
Dogs
Control dogs
number 
of dogs
B. burgdorferi 
positive [%]
number 
of dogs
B. burgdorferi 
positive [%]
Was the area you lived in rural or urban1 Rural 136 59 37 11
Urban 6 50 10 30
Did your dogs have access to the house or did he live only in a kennel? Access to house 127 56 41 17
Kennel only 16 81 6 0
Had your dogs access to a run? Yes 136 60 45 16
No 7 43 2 0
Could your dog escape from the house or the run? Yes 28 50 4 0
No 115 61 43 16
How often did you walk the dog a day? 1 time 68 62 18 11
2 times 51 57 16 19
3 times 20 50 8 0
>3 times 3 67 5 40
What percentage (%) of time did you spend in the woods on your 
walks?2
Range 0–100 0–100
Median 50 50
1Significant difference between Bernese Mountain Dogs and control dogs (p = 0.001).
2Bernese Mountain Dogs with antibodies against B. burgdorferi spent a significantly higher percentage of time in the woods on walks than those 
without (p = 0.049).
Table 4: Results of serologic testing for B. burgdorferi
Bernese Mountain Dogs (n = 160) Control dogs (n = 62)
Serology* number of dogs % number of dogs % coat color
fair dark
positive1,2 92 58 9 15 3 6
negative 68 42 53 85 38 15
total 160 100 62 100 41 21
* ELISA and Western blot positive
1Significant difference between Bernese Mountain Dogs and control dogs (p < 0.001).
2Significant difference between control dogs with fair and dark coat color (p < 0.03).BMC Veterinary Research 2007, 3:15 http://www.biomedcentral.com/1746-6148/3/15
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tion in the ELISA. Antibodies against leptospires are
known to cross-react with antibodies against B. burgdorferi
and it was found that antibodies against leptospires are
common in healthy dogs in Switzerland [33,34]. Results
of the microscopic agglutination test (MAT) for antibod-
ies against leptospires showed that there was no influence
of leptospires on the results of antibody tests for B. burg-
dorferi. Vaccination can influence ELISA results [35]. In
Switzerland dogs are rarely vaccinated against B. burgdor-
feri and in the present study only 10 dogs were vaccinated,
which did not seem to influence the study results.
There are different ways in which Western blot results can
be interpreted [36]. In the present study criteria were used
that were established in Europe because European B. burg-
dorferi strains are different from strains in the USA. Also
the antibody response of European human patients with
Lyme Borreliosis was found to be variable and more
restricted than that in U.S. patients [37,38]. Antibody
response seemed stronger in seropositive Bernese Moun-
tain Dogs compared to positive control dogs in this study
as the reaction in the ELISA was stronger. Rather than dif-
ferences in spirochete strains, in duration of the infection
or in number of reinfections, differences in the immune
response of the hosts are a possible explanation for this
finding.
Conclusion
In conclusion this study showed that Bernese Mountain
Dogs more often had antibodies against B. burgdorferi
compared to control dogs. Breed predisposition for anti-
bodies against B. burgdorferi has not been reported before.
More investigations are needed to evaluate the biological
reasons and consequences of infections with B. burgdorferi
in Bernese Mountain Dogs.
Methods
Samples and dogs
The dogs whose owners belonged to the Club for Bernese
Mountain Dogs in Switzerland were defined as the popu-
lation to be examined. The number of dogs needed to pre-
dict the prevalence of antibodies in this population was
calculated using the statistical software EpiInfo 6.1
(WHO, Genf, 1997). At least 131 Bernese Mountain Dogs
were needed to predict an estimated prevalence of 10%
with an accuracy of 5%. The prevalence of 10% was esti-
mated according to prevalences found in the literature.
The minimum number of control dogs needed was calcu-
lated using the software WinEpiscope 2.0 (Nacho de Blas,
Zaragossa, Spain, available online). The control dogs were
to be long haired, large breed dogs resembling the Bernese
Mountain Dogs in size and hair coats. The hair coat color
of the control dogs was classified either as dark (similar to
Bernese Mountain Dogs) or as fair.
Owners were contacted and volunteered to join the study
after a call from the Swiss Club for Bernese Mountain
Dogs and the Swiss Newfoundland and Landseer club.
Others were directly contacted if it was known that they
owned a dog eligible for the study.
Samples were collected between July 2002 and April
2003.
Dogs were included in the study if they were older than 4
months. The dogs were healthy according to the owners
with no obvious signs of a specific disease evaluated by a
complete blood count, a serum biochemical analysis and
Number of positive bands depicted in a Western blot for B.  burgdorferi from serum of Bernese Mountain Dogs and con- trol dogs Figure 3
Number of positive bands depicted in a Western blot 
for B. burgdorferi from serum of Bernese Mountain 
Dogs and control dogs. BMD = Bernese Mountain Dogs, 
B.b. = Borrelia burgdorferi
B. burgdorferi ELISA results (optical density 405 nm) from  Bernese Mountain Dogs and control dogs Figure 2
B. burgdorferi ELISA results (optical density 405 nm) 
from Bernese Mountain Dogs and control dogs. OD = 
optical density, BMD = Bernese Mountain Dogs, B.b. = Borre-
lia burgdorferi
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O
D
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urinalysis. Serum biochemical analysis included determi-
nation of bilirubin, glucose, urea, creatinine, total protein,
albumin, cholesterol, sodium, potassium, chloride, cal-
cium and phosphorus concentrations and measurement
of the activity of alkaline phosphatase, alanine trans-
ferase, aspartate transferase and amylase. Urinalysis
included urine test strip (Combur-Test®, Roche Diagnos-
tics GmbH, Mannheim Germany), microscopic examina-
tion of urine sediment and determination of urine specific
gravity and urine protein:creatinine ratio. The geographi-
cal area of Switzerland where the dogs originated was not
previously determined and depended on the place where
owners who wanted to join the study lived. Each owner
was asked to complete a questionnaire and give informa-
tion about the health status of the dog (Table 2). One spe-
cific question was whether the dog often had attached
ticks. However the category "often" was not further speci-
fied.
The environment in which the dogs lived was investigated
in retrospect by telephone interview (Table 3).
Serologic testing
An enzyme-linked immunosorbent assay (ELISA) for the
detection of antibodies against B. burgdorferi sensu lato was
performed in all dogs according to a method described
earlier [39]. Briefly a whole cell sonicate of B. burgdorferi
sensu stricto reference strain B31 (ATCC 35210) was used
as antigen. The samples were previously absorbed with a
heterologous sorbant consisting of washed formalin inac-
tivated whole cells of E. coli, Salmonella typhimurium, Bra-
chispira hyodysenteriae,  Bacillus subtilis and leptospires
comprising 18 serovars. Western blot examinations for
the detection of antibodies against B. burgdorferi were per-
formed in all but one dog. A commercial test kit adapted
for dogs was used (Virion Ltd., Rüschlikon, Switzerland).
The tests which were performed according to the manu-
facturer's instructions consisted of Western blot strips
with defined partial antigens of B. burgdorferi ss. and B.
afzelii. In preliminary tests with positive and negative dog
serum, a dilution of 1:200 and a conjugate (alkaline-
phosphatase-rabbit-anti-dog IgG, H+L, Sigma, Diesen-
hofen, Switzerland) dilution of 1: 2000 was considered
adequate. The interpretation of the Western blot results
was done according to the interpretation criteria recom-
mended for three European species of B. burgdorferi sensu
lato [37]. Samples were considered positive if bands at the
level of the partial antigens p100, p58, OspC, p21 or
wb18 were identified or if at least two bands at the level of
the partial antigens p45, bmpa und wb30 were present.
Bands at the level of the partial antigens OspB, OspA,
OspD, wb22 und OspE were considered unspecific.
For the microscopic agglutination test (MAT) to detect
antibodies against leptospires, the ten most commonly
recognized serovars (sv.) in Switzerland were used as anti-
gens: Leptospira interrogans, sv.: australis, bratislava, autum-
nalis, bataviae, canicola, grippotyphosa, icterohaemorrhagiae
and pomona; Leptospira borgpetersenii, sv.: hardjo and tarass-
ovi.
Statistical analysis
Data were recorded and analyzed using a commercial
computer program (Statistical Package for the Social Sci-
ences for Windows version 11, SPSS Inc., Chicago Il,
USA). Between Bernese Mountain Dogs and control dogs
variables were compared using the Mann-Whitney U test
for the evaluation of age, optical density, percentage of
time spent in the woods and a Fisher's exact test for all
other data. Differences were considered significant at p <
0.05.
Authors' contributions
BG: Designed the study, analyzed the data and drafted the
manuscript.
SE: Contributed to the study design, collected the data and
contributed to the manuscript drafting and data interpre-
tation.
MMW: Performed the serologic tests, was involved in the
study design and the drafting of the manuscript
CER: Was involved in the study design and coordination
and contributed to the critical evaluation and interpreta-
tion of the data.
Acknowledgements
We thank the owners who volunteered to join the study after a call from 
the Swiss Club for Bernese Mountain Dogs. This work was supported by 
the Swiss Club for Bernese Mountain Dogs, the Albert Heim Foundation 
and Novartis Animal Health Switzerland
References
1. Dambach DM, Smith CA, Lewis RM, Van Winkle TJ: Morphologic,
immunohistochemical, and ultrastructural characterization
of a distinctive renal lesion in dogs putatively associated with
Borrelia burgdorferi infection: 49 cases (1987–1992).  Vet
Pathol 1997, 34:85-96.
2. Grauer GF, Burgess EC, Cooley AJ, Hagee JH: Renal lesions asso-
ciated with Borrelia burgdorferi infection in a dog.  J Am Vet
Med Assoc 1988, 193:237-239.
3. Magnarelli LA, Anderson JF, Schreier AB, Ficke CM: Clinical and
serologic studies of canine borreliosis.  J Am Vet Med Assoc 1987,
191:1089-1094.
4. Minkus G, Breuer W, Wanke R, Reusch C, Leuterer G, Brem G, Her-
manns W: Familial nephropathy in Bernese mountain dogs.
Vet Pathol 1994, 31:421-428.
5. Reusch C, Hoerauf A, Lechner J, Kirsch M, Leuterer G, Minkus G,
Brem G: A new familial glomerulonephropathy in Bernese
mountain dogs.  Vet Rec 1994, 134:411-415.
6. Houston DM, Ribble CS, Head LL: Risk factors associated with
parvovirus enteritis in dogs: 283 cases (1982–1991).  J Am Vet
Med Assoc 1996, 208:542-546.
7. Arnold S, Müller A, Binder H, Meyers K, Giger U: Von Willebrand
factor concentrations in blood plasma of Bernese mountain
dogs.  Schweiz Arch Tierheilkd 1995, 139:177-182.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Veterinary Research 2007, 3:15 http://www.biomedcentral.com/1746-6148/3/15
Page 8 of 8
(page number not for citation purposes)
8. Kraus KH, Johnson GS: Von Willebrand's disease in dogs.  In Cur-
rent Veterinary Therapy X Edited by: Kirk RW, Bonagura JD. Philadel-
phia: W.B. Saunders Company; 1989:446-452. 
9. Kathmann I, Jaggy A, Busato A, Bartschi M, Gaillard C: Clinical and
genetic investigations of idiopathic epilepsy in the Bernese
mountain dog.  J Smal Anim Pract 1999, 40:319-325.
10. Padgett GA, Madewell BR, Keller ET, Jodar L, Packard M: Inherit-
ance of histiocytosis in Bernese mountain dogs.  J Small Anim
Pract 1995, 36:93-8.
11. Voegeli E, Welle M, Hauser B, Dolf G, Fluckiger M: Histiocytic sar-
coma in the Swiss population of Bernese mountain dogs: a
retrospective study of its genetic predisposition.  Schweiz Arch
Tierheilkd 2006, 148:281-288.
12. Watson PJ, Wotton P, Eastwood J, Swift ST, Jones B, Day MJ: Immu-
noglobulin deficiency in Cavalier King Charles Spaniels with
Pneumocystis pneumonia.  J Vet Intern Med 2006, 20:523-527.
13. Cohen ND, Carter CN, Thomas MA, Angulo AB, Eugster AK: Clini-
cal and epizootiologic characteristics of dogs seropositive for
Borrelia burgdorferi in Texas: 110 cases (1988).  J Am Vet Med
Assoc 1990, 197:893-898.
14. Alitalo A, Meri T, Ramo L, Jokiranta TS, Heikkila T, Seppala IJ, Oksi J,
Viljanen M, Meri S: Complement evasion by Borrelia burgdorferi:
serum-resistant strains promote C3b inactivation.  Infect
Immun 2001, 69:3685-3691.
15. Wormser GP, Kaslow R, Tang J, Wade K, Liveris D, Schwartz I,
Klempner M: Association between human leukocyte antigen
class II alleles and genotype of Borrelia burgdorferi in
patients with early lime disease.  J Infect Dis 2005,
192:2020-2026.
16. Yunis EJ, Larsen CE, Fernandez-Vina M, Awdeh ZL, Romero T,
Hansen JA, Alper CA: Inheritable variable sizes of DNA
stretches in human MHC: conserved extended haplotypes
and their fragments or blocks.  Tissue Antigens 2003, 62:1-20.
17. Sjöwall J, Carlsson A, Vaarala O, Bergstrom S, Ernerudh J, Forsberg P,
Ekerfelt C: Innate immune responses in Lyme borreliosis:
enhanced tumor necrosis factor-alpha and interleukin-12 in
asymptomatic individuals in response to live spirochetes.  Clin
Exp Immunol 2005, 141:89-98.
18. Blum JR, Cork LC, Morris JM, Olson JL, Winkelstein JA: The clinical
manifestation of a genetically determined deficiency of the
third component of complement in the dog.  Clin Immunol
Immunop 1985, 34:304-315.
19. Aeschlimann A, Chamot E, Gigon F, Jeanneret JP, Kesseler D, Walther
Ch:  B. burgdorferi in Switzerland.  Zbl Bakt Hyg A 1986,
263:450-458.
20. Jouda F, Crippa M, Perret J, Gern L: Distribution and prevalence
of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks of
canton Ticino (Switzerland).  Eur J Epidemiol 2003, 18:907-912.
21. Jouda F, Perret J, Gern L: Density of questing Ixodes ricinus
nymphs and adults infected by Borrelia burgdorferi sensu
lato in Switzerland: spatio-temporal pattern at a regional
scale.  Vector Borne Zoonotic Dis 2004, 4:23-32.
22. Jouda F, Perret J-L, Gern L: Ixodes ricinus density, and distribu-
tion and prevalence of Borrelia burgdorferi sensu lato infec-
tion along an altitude gradient.  J Med Entomol 2004, 41:162-169.
23. Miserez V, Gern L, Aeschlimann A: Borrelia burgdorferi in ticks
of the canton Tessin (Switzerland).  Parasitologia 1990,
32:293-299.
24. Péter O, Bretz A-G, Bee D: Occurrence of different genospecies
of Borrelia burgdorferi sensu lato in ixodid ticks of Valais,
Switzerland.  Eur J Epidemiol 1995, 11:463-467.
25. Wicki R, Sauter P, Mettler C, Natsch A, Enzler T, Pusterla N, Kuhnert
P, Egli G, Bernasconi M, Lienhard R, Lutz H, Leutenegger CM: Swiss
Army survey in Switzerland to determine prevalence of
Francisella tularensis, members of the Ehrlichia phagocy-
tophila genogroup, Borrelia burgdorferi sensu lato, and tick-
borne encephalitis virus in ticks.  Eur J Clin Microbiol 2000,
19:427-432.
26. Goossens HAT, van den Bogaard AE, Nohlmans MKE: Dogs as sen-
tinels for human Lyme borreliosis in the Netherlands.  J Clin
Microbiol 2001, 39:844-848.
27. Guerra M, Walker E, Kitron U: Canine surveillance system for
Lyme borreliosis in Wisconsin and Northern Illinois: Geo-
graphic distribution and risk factor analysis.  Am J Trop Med Hyg
2001, 65:546-552.
28. Crippa M, Rais O, Gern L: Investigations on the mode and
dynamics of transmission and infectivity of Borrelia burgdor-
feri sensu stricto and Borrelia afzelii in Ixodes ricinus ticks.
Vector Borne Zoonotic Dis 2002, 2:3-9.
29. DeSilva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E: Borrelia
burgdorferi OspA is an arthropod-specific transmission-
blocking Lyme disease vaccine.  J Exp Med 1996, 183:271-275.
30. Shih CM, Pollack RJ, Telford SR 3rd, Spielman A: Delayed dissemi-
nation of Lyme disease spirochetes from the site of deposi-
tion in the skin of mice.  J Infect Dis 1993, 166:827-831.
31. Stjernberg L, Berglund J: Detecting ticks on light versus dark
clothing.  Scand J Infect Dis 2005, 37:361-364.
32. Magnarelli LA, Ijdo JW, Padula SJ, Flavell RA, Fikrik E: Serologic
diagnosis of Lyme borreliosis by using enzyme-linked immu-
nosorbent assays with recombinant antigens.  J Clin Microbiol
2000, 38:1735-1739.
33. Shin SJ, Chang YF, Jacobson RH, Shaw E, Lauderdale TL, Appel MJ,
Lein DH: Cross-reactivity between B. burgdorferi and other
spirochetes affects specificity of serotests for detection of
antibodies to the Lyme disease agent in dogs.  Clin Microbiol
1993, 36:161-174.
34. Steger-Lieb A, Gerber B, Nicolet J, Gaschen F: An old disease with
a new face: canine leptospirosis does not lose its relevance.
Schweiz Arch Tierheilkd 1999, 141:499-507.
35. Guerra M, Walker E, Kitron U: Quantitative approach for the
serodiagnosis of canine Lyme disease by the Immunoblot
procedure.  J Clin Microbiol 2000, 38:2628-2632.
36. Littman MP: Canine borreliosis.  Vet Clin N Am Small Anim Pract
2003, 33:827-862.
37. Hauser U, Lehnert G, Lobentanzer R, Wilske B: Interpretation cri-
teria for standardized western blots for three European spe-
cies of Borrelia burgdorferi sensu lato.  J Clin Microbiol 1997,
35:1433-1444.
38. Dressler F, Ackermann R, Steere AC: Antibody responses to the
three genomic groups of Borrelia burgdorferi in European
Lyme borreliosis.  J Infect Dis 1994, 169:313-318.
39. Wittenbrink M, Failing K, Krauss H: Enzyme-linked immunosorb-
ent assay and immunoblot analysis for detection of antibod-
ies to Borrelia burgdorferi in dogs. The impact of serum
absorption with homologous and heterologous bacteria.  Vet
Microbiol 1996, 48:257-268.